title: [How to improve the results of treatment of myelodysplastic syndromes in the studies of Polish pediatric leukemia/lymphoma group].
abstract: Fourty two children with myelodysplastic syndrome (MDS) treated in seven centres of The Polish Paediatric Leukaemia/Lymphoma Study Group in period 1975-1998 were included in the study. In 16 children RAEB-T, in 3 CMML, in 10 RA and in 13 RAEB were diagnosed. BMT is the best therapy for children with MDS. For children, who have not a donor for BMT, Roacutan therapy seems to be the most effective.
authors.affiliation: Kliniki Hematologii i Chorób Rozrostowych Dzieci Akademii Medycznej we Wrocławiu.
authors.forename: A
authors.initials: A
authors.lastname: Chybicka
authors.forename: P
authors.initials: P
authors.lastname: Kołecki
authors.forename: W
authors.initials: W
authors.lastname: Pietras
authors.forename: D
authors.initials: D
authors.lastname: Wójcik
authors.forename: D
authors.initials: D
authors.lastname: Turkiewicz
authors.forename: J
authors.initials: J
authors.lastname: Armata
authors.forename: A
authors.initials: A
authors.lastname: Eliasińska
authors.forename: J
authors.initials: J
authors.lastname: Kowalczyk
authors.forename: T
authors.initials: T
authors.lastname: Jackowska
authors.forename: K
authors.initials: K
authors.lastname: Klus
authors.forename: M
authors.initials: M
authors.lastname: Matysiak
authors.forename: A
authors.initials: A
authors.lastname: Krauze
authors.forename: K
authors.initials: K
authors.lastname: Stefańska
authors.forename: R
authors.initials: R
authors.lastname: Rokicka-Milewska
authors.forename: H
authors.initials: H
authors.lastname: Wiśniewska-Slusarz
mesh_terms: D000293:Adolescent; D000465:Algorithms; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents